Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance

Jia-Wen Chen1,2, Sibao Chen1,2,3,4, Guo-Qing Chen2,3,4

  • 1Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.

Insights

Cancer cells evade apoptosis, a common drug target. This review explores non-apoptotic cell death pathways like ferroptosis, necroptosis, pyroptosis, and paraptosis, and natural compounds that can overcome drug resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis evasion is a key mechanism of cancer drug resistance.
  • Novel therapeutic strategies are needed to overcome treatment failures.
  • Non-apoptotic cell death pathways offer alternative targets for cancer therapy.

Purpose of the Study:

  • To review recent advancements in non-apoptotic cell death mechanisms (ferroptosis, necroptosis, pyroptosis, paraptosis) for cancer treatment.
  • To highlight the role of natural compounds in overcoming cancer drug resistance.
  • To explore the potential of natural compounds in inducing these alternative cell death pathways.

Main Methods:

  • Literature review of studies on non-apoptotic cell death.
  • Analysis of research on natural compounds with anticancer properties.
  • Synthesis of findings regarding the induction of ferroptosis, necroptosis, pyroptosis, and paraptosis by natural products.

Main Results:

  • Natural compounds can effectively induce ferroptosis, necroptosis, pyroptosis, and paraptosis.
  • These mechanisms provide alternative routes to eliminate cancer cells resistant to apoptosis.
  • Numerous natural compounds demonstrate significant anticancer and anti-resistance effects.

Conclusions:

  • Non-apoptotic cell death pathways are promising strategies to combat cancer drug resistance.
  • Natural compounds represent a valuable resource for developing novel anti-cancer therapies that bypass resistance.
  • Targeting these alternative cell death mechanisms with natural products offers a viable approach to enhance cancer treatment efficacy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K